| scholarly article | Q13442814 |
| P356 | DOI | 10.3201/EID2311.171130 |
| P8608 | Fatcat ID | release_5wkhkrvdivevxk7e6i5kayscqu |
| P932 | PMC publication ID | 5652432 |
| P698 | PubMed publication ID | 29048285 |
| P50 | author | Christi L McElheny | Q114435273 |
| Adam D Tomich | Q114435274 | ||
| Vaughn S. Cooper | Q41050411 | ||
| Minggui Wang | Q43119922 | ||
| Yohei Doi | Q73186070 | ||
| Nicolas Sluis-Cremer | Q113121065 | ||
| P2093 | author name string | Yan Guo | |
| Fupin Hu | |||
| Louis B Rice | |||
| Amelia Tait-Kamradt | |||
| P2860 | cites work | Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies | Q33472890 |
| Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012. | Q33732529 | ||
| The fosfomycin resistance gene fosB3 is located on a transferable, extrachromosomal circular intermediate in clinical Enterococcus faecium isolates | Q35036048 | ||
| Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance. | Q36290521 | ||
| Fosfomycin: Resurgence of an old companion. | Q36803694 | ||
| Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release | Q37866109 | ||
| Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? | Q38064807 | ||
| Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosis | Q47904411 | ||
| Lyme disease enolpyruvyl-UDP-GlcNAc synthase: fosfomycin-resistant MurA from Borrelia burgdorferi, a fosfomycin-sensitive mutant, and the catalytic role of the active site Asp. | Q48060200 | ||
| A broad-host-range mobilizable shuttle vector for the construction of transcriptional fusions to beta-galactosidase in gram-positive bacteria. | Q54144084 | ||
| Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. | Q54590227 | ||
| P433 | issue | 11 | |
| P921 | main subject | Enterococcus faecium | Q140010 |
| P304 | page(s) | 1902-1904 | |
| P577 | publication date | 2017-11-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium | |
| P478 | volume | 23 |
| Q61455372 | Molecules that Inhibit Bacterial Resistance Enzymes |
| Q64886188 | New microbiological aspects of fosfomycin. |
| Q91789304 | Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model |
Search more.